Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Healthequity (HQY) Invested Capital (2016 - 2026)

Healthequity has reported Invested Capital over the past 13 years, most recently at $3.1 billion for Q1 2026.

  • For Q1 2026, Invested Capital fell 3.36% year-over-year to $3.1 billion; the TTM value through Jan 2026 reached $3.1 billion, down 3.36%, while the annual FY2026 figure was $3.1 billion, 3.36% down from the prior year.
  • Invested Capital for Q1 2026 was $3.1 billion at Healthequity, down from $3.1 billion in the prior quarter.
  • Over five years, Invested Capital peaked at $3.3 billion in Q3 2024 and troughed at $2.8 billion in Q1 2022.
  • A 5-year average of $3.0 billion and a median of $2.9 billion in 2024 define the central range for Invested Capital.
  • Biggest five-year swings in Invested Capital: increased 17.67% in 2022 and later fell 3.36% in 2026.
  • Year by year, Invested Capital stood at $2.8 billion in 2022, then increased by 1.86% to $2.9 billion in 2023, then grew by 12.0% to $3.2 billion in 2024, then decreased by 2.79% to $3.1 billion in 2025, then fell by 1.65% to $3.1 billion in 2026.
  • Business Quant data shows Invested Capital for HQY at $3.1 billion in Q1 2026, $3.1 billion in Q4 2025, and $3.2 billion in Q3 2025.